Navigation Links
Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org
Date:8/1/2014

Dallas, Texas (PRWEB) August 01, 2014

Growing prevalence of chronic ailments, medical tourism, universal health coverage and healthcare reforms are boosting healthcare market growth, although a reduction in the price of medicines through discounts and increasing generic consumption is a major challenge.

Turkey’s population stood at approximately 76.7 million in 2013, having grown at a Compound Annual Growth Rate (CAGR) of 1.4%, from 2008. The implementation of the Health Transformation Program (Saglikta Donus, um Programi, HTP) resulted in social security reforms that were aimed at improving the universal health coverage. The available infrastructure for healthcare industries and the high number of healthcare institutions makes Turkey an attractive location for the manufacture and marketing of pharmaceutical products.

Complete report details at http://www.marketoptimizer.org/countryfocus-healthcare-regulatory-and-reimbursement-landscape-turkey.html.

The government is trying to increase pharmaceutical R&D in Turkey, and in 2012, it introduced a new investment incentives program that had four basic schemes to increase foreign investment. The pharmaceutical market was worth approximately $12.5 billion, in 2012, and was the sixth-largest pharmaceutical market in Europe. It is set to grow at a CAGR of 7.3% from 2008 to reach $21.5 billion in 2020. The medical device market was valued at approximately $1.9 billion in 2008 and is estimated to grow at a CAGR of 4.7% to reach an estimated $3.3 billion in 2020. These positive growth trends can be primarily attributed to:

  • An increasing elderly population
  • Universal health coverage
  • Government initiatives

The available infrastructure for healthcare industries and the high number of healthcare institutions makes Turkey an attractive location for the manufacture and marketing of pharmaceutical products. Medical tourism is another driving factor of the pharmaceutical industry. In 2012, Turkey received 270,000 foreign patients. Services for medical tourism are primarily provided by private hospitals, and the government provides tax exemptions for private hospitals, to encourage medical tourism (MoH, 2012c).

Order a purchase copy at http://www.marketoptimizer.org/contacts/purchase?rname=9228.

The government is also trying to increase pharmaceutical R&D. In 2012, it introduced a new investment incentives program, which has four basic schemes for increasing foreign investment. There are 150 R&D centers in Turkey, and in April 2013 Dupont opened its 11th innovation center (ISPAT, 2013a).

The price of medicine is very low, compared with other EU countries (AiFD, 2007). Turkey uses a reference pricing system in combination with discounts for the sale of its pharmaceuticals. In 2009, to curb changes in the price of medicine, the government fixed the euro to the lira conversion rate (Bilmen, 2014). These factors greatly reduce the profit margin for pharmaceutical companies, making pricing a major challenge for the growth of the pharmaceutical market. In addition, the use of generics is high: in 2012, 53% of the drugs consumed were generics (MoH, 2012). The usage of generics is expected to grow and thus mitigate the growth of the market.

There is a large market for medical devices due to the growing elderly population and subsequent increase in demand for healthcare products and services. The medical device market was valued at approximately $1.9 billion in 2008 and is estimated to grow at a CAGR of 4.7% to reach $3.3 billion in 2020. Turkey predominantly depends on imports for its medical devices, as many of its domestic producers are involved with products that do not require high technology.

Healthcare workers are not uniformly distributed among the 81 provinces of Turkey. In 2007, the lowest number of specialized physicians per 1,000 population was 0.19, in Sirnak. The highest number of specialized physicians per 1,000 population was 2.57, in Ankara (Vujicic et al, 2009).

Turkish regulatory authority does not provide transparent and efficient regulatory system to facilitate approval of pharmaceutical products and medical devices.

With the help of the European community, there was rapid growth between 2002 and 2012. Annual Gross Domestic Product (GDP) growth was 5% higher than in most OECD countries, where it averaged 1% (ISPAT, 2013b). In May 2013, Turkey paid off the last installment ($412m) of its debt to the International Monetary Fund (IMF) (Today’s Zaman, 2013). GDP per capita was $10,815, in 2013, and is expected to increase (IMF, 2014a). Gross National Income (GNI) per capita was an estimated at $11,238 in 2013 (World Bank, 2014c). Turkey plans to implement monetary and financial policies to lower the inflation rate and increase the foreign exchange reserve.

Explore more reports on Healthcare industry at http://www.marketoptimizer.org/category/life-sciences/healthcare.

About Us:
MarketOptimizer.org is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Read the full story at http://www.prweb.com/releases/2020-turkey-healthcare/regulatory-reimbursement/prweb12065923.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Dinner-Table Turkeys Differ Greatly From Their Ancestors
2. Consumer Reports Tests: Bacteria on Turkey Raised Without Antibiotics Showed Significantly Less Antibiotic Resistance than Bacteria Conventional Turkey
3. Hepatitis A Outbreak in Costco Organic Berry Blend Linked to Pomegranate Imported From Turkey
4. Medical Device Consultancy Emergo Group Opens Offices in Turkey and South Africa
5. Austin Heart Patient Will Race in Annual Thanksgiving Turkey Trot to Mark his Recovery, Inspire People with Heart Disease
6. Reel FX, Relativity Media and the Dallas YMCA Turkey Trot Form Partnership for Upcoming Animated Film “Free Birds” Starring Owen Wilson, Woody Harrelson and Amy Poehler
7. Holiday Season is Perfect Time to “Talk Turkey” about End-of-Life Care Wishes
8. In animal study, cold turkey withdrawal from drugs triggers mental decline
9. Turkey Included to the Web’s Best Medical Tourism Directory as myMEDholiday Continues Expansion of Prime Medical Tourism Destinations
10. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
11. MSU invention could help pharmaceutical industry save money
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Island, SC (PRWEB) , ... February 08, 2016 , ... ... surrounding areas with a vital new community enrichment program, has teamed up with Citizens ... women and children suffering from intimate abuse. To support all those victimized by the ...
(Date:2/8/2016)... , ... February 08, 2016 ... ... security executive networking and relationship-marketing firm, announced today that nominations will be ... Security Executive® (ISE®) West Awards. , Awards include the Information Security ...
(Date:2/8/2016)... ... 2016 , ... Discover the Rocky Mountain region’s longest running and impressive garden ... Attendees also get to see the most incredible gardens and home improvement experts that ... the Colorado Convention Center - 700 14th St. Denver CO, is an exciting event ...
(Date:2/8/2016)... ... February 08, 2016 , ... Joshua Rosenthal, ... how healthcare companies can use newly released government data on populations and physicians ... and intervene and capture the value they create to succeed in new economic ...
(Date:2/7/2016)... ... February 07, 2016 , ... Women’s Excellence ... and the most minimally invasive approaches. , Women who have had multiple vaginal ... risk factors include surgery to the pelvic floor, connective tissue disorders, and obesity. ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... Velano Vascular, a medical technology company transforming ... their practitioners, announced today that the company has raised ... the proceeds from this financing, an extension of a ... to support the development and commercialization of the company,s ... Philadelphia , and a number ...
(Date:2/8/2016)... Therapeutics, Inc. announced today that the United States Patent and ... the use of NephroFlow to treat acute kidney injury (AKI). ... "We are pleased to secure our rights to such a ... HemaFlo,s founder, said, "We are pleased to secure our rights ... Dale Peterson , PhD, HemaFlo,s founder, said, "We are pleased ...
(Date:2/8/2016)...  Astellas Pharma Inc. President and Chief Executive Officer ... Robinson as president, Americas Operations, for Astellas US LLC, ... South America , effective April 1, 2016.  Robinson ... organization in the United States -- ... Yoshida , who is retiring in June 2016.  ...
Breaking Medicine Technology: